Patient characteristics
| Characteristics | |
|---|---|
| No. | 100 |
| Male | 60 |
| Female | 40 |
| Age (mean) (yr) | 11.9 ± 5.5 |
| Primary diagnosis (No.) (%) | |
| Hematologic malignancy | 65, 65% |
| Acute myeloid leukemia | 34, 34% |
| Acute lymphoblastic leukemia | 17, 17% |
| Hodgkin lymphoma | 8, 8% |
| Myelodysplastic syndrome | 5, 5% |
| Anaplastic large-cell lymphoma | 1, 1% |
| Hematologic disorder | 5, 5% |
| Severe aplastic anemia | 3, 3% |
| Sickle cell disease | 2, 2% |
| Solid tumor | 28, 28% |
| Neuroblastoma | 15, 15% |
| Ewing sarcoma | 9, 9% |
| Germ cell tumor | 3, 3% |
| Desmoplastic small round cell tumor | 1, 1% |
| Immune disorder | 2, 2% |
| Severe combined immunodeficiency | 1. 1% |
| Wiskott-Aldrich syndrome | 1, 1% |
| Transplant donor (No.) (%) | |
| Allogenic | 66, 66% |
| Autologous | 34, 34% |
| Disease status at transplantation (No.) (%) | |
| Complete remission | 82, 82% |
| Active disease | 18, 18% |
| T-cell depletion (No.) (%) | 2, 2% |
| GVHD II–IV (No.) (%) | 15, 15% |